Health Care & Life Sciences » Biotechnology | Genetic Signatures Ltd.

Genetic Signatures Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,852.70
5,461.70
2,564.30
13,193.00
8,954.80
Total Accounts Receivable
731.70
1,405.50
1,915.10
2,457.00
3,322.70
Inventories
-
191.50
754.30
762.60
1,181.10
Total Current Assets
2,584.40
7,058.70
5,233.70
16,412.50
13,458.60
Net Property, Plant & Equipment
395.30
741.40
729.50
1,262.40
1,150.00
Total Assets
2,979.70
7,800.10
5,963.20
17,674.90
14,608.50
Accounts Payable
87.00
263.60
573.00
617.30
541.90
Other Current Liabilities
281.80
474.10
703.10
567.00
657.00
Total Current Liabilities
368.80
737.80
1,276.10
1,184.30
1,198.90
Provision for Risks & Charges
1.70
5.40
7.40
5.50
10.50
Total Liabilities
370.50
743.10
1,283.50
1,189.80
1,209.50
Common Equity (Total)
2,609.20
7,057.00
4,679.70
16,485.10
13,399.10
Total Shareholders' Equity
2,609.20
7,057.00
4,679.70
16,485.10
13,399.10
Total Equity
2,609.20
7,057.00
4,679.70
16,485.10
13,399.10
Liabilities & Shareholders' Equity
2,979.70
7,800.10
5,963.20
17,674.90
14,608.50

About Genetic Signatures

View Profile
Address
7 Eliza Street
Newtown New South Wales (NSW) 2042
Australia
Employees -
Website http://www.geneticsignatures.com
Updated 07/08/2019
Genetic Signatures Ltd. engages in the research and commercialization of identifying individual genetic signatures to identify diseases and disabilities. Its molecular diagnostics, 3Base, provides high-volume hospital and pathology laboratories the ability to screen wide array of infectious pathogens. The firm also designs and manufactures suite of real-time polymerase chain reaction based products for the routine detection of infectious diseases under the EasyScreen brand.